Literature DB >> 3530645

A randomized comparison of nifedipine and sodium nitroprusside in severe hypertension.

C Franklin, S Nightingale, B Mamdani.   

Abstract

We randomized patients with severe hypertension in the Medical Intensive Care Unit to a treatment regimen of oral nifedipine or intravenous nitroprusside. Patients treated with nifedipine achieved a sustained reduction in diastolic blood pressure to less than or equal to 120 mm Hg in an average of less than five hours. Patients treated with nitroprusside achieved a similar reduction in 14 hours (p less than 0.05). Treatment with nifedipine was less expensive and required less time in the ICU than treatment with nitroprusside and was accompanied by no associated increase in morbidity or mortality. Oral nifedipine can be used as an alternative to intravenous nitroprusside in severe uncomplicated hypertension.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530645     DOI: 10.1378/chest.90.4.500

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  The use of pharmaceuticals in critical care. The importance of outcome prediction models.

Authors:  G D Clifton; K Blumenschein
Journal:  Pharmacoeconomics       Date:  1995-05       Impact factor: 4.981

Review 2.  Management of patients with hypertensive urgencies and emergencies: a systematic review of the literature.

Authors:  David Cherney; Sharon Straus
Journal:  J Gen Intern Med       Date:  2002-12       Impact factor: 5.128

Review 3.  Comparative tolerability profile of hypertensive crisis treatments.

Authors:  E Grossman; A N Ironi; F H Messerli
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

Review 4.  Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

Review 5.  Pharmacological interventions for hypertensive emergencies.

Authors:  M I Perez; V M Musini
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.